To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Rothschild healthcare exit may reach 10x
The Paris-based firm, which invested $10m in Vessix Vascular in June 2011, has exited the business, generating an initial 3.5x return multiple that could increase up to 10x in the next three years.
